These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 23484963)

  • 1. Virtual screening of the estrogen receptor.
    Knox AJ; Yang Y; Lloyd DG; Meegan MJ
    Expert Opin Drug Discov; 2008 Aug; 3(8):853-66. PubMed ID: 23484963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target specific virtual screening: optimization of an estrogen receptor screening platform.
    Knox AJ; Meegan MJ; Sobolev V; Frost D; Zisterer DM; Williams DC; Lloyd DG
    J Med Chem; 2007 Nov; 50(22):5301-10. PubMed ID: 17918820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of estrogen receptor modulators: a review of virtual screening and SAR efforts.
    Xu X; Yang W; Li Y; Wang Y
    Expert Opin Drug Discov; 2010 Jan; 5(1):21-31. PubMed ID: 22823969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacophore-based evolutionary approach for screening selective estrogen receptor modulators.
    Yang JM; Shen TW
    Proteins; 2005 May; 59(2):205-20. PubMed ID: 15726586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
    Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
    J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a minimal subset of receptor conformations for improved multiple conformation docking and two-step scoring.
    Yoon S; Welsh WJ
    J Chem Inf Comput Sci; 2004; 44(1):88-96. PubMed ID: 14741014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided identification of novel protein targets of bisphenol A.
    Montes-Grajales D; Olivero-Verbel J
    Toxicol Lett; 2013 Oct; 222(3):312-20. PubMed ID: 23973438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of binary QSAR models derived from LUDI and MOE scoring functions for structure based virtual screening.
    Prathipati P; Saxena AK
    J Chem Inf Model; 2006; 46(1):39-51. PubMed ID: 16426038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchical virtual screening: identification of potential high-affinity and selective β(3)-adrenergic receptor agonists.
    Saxena AK; Roy KK
    SAR QSAR Environ Res; 2012 Jul; 23(5-6):389-407. PubMed ID: 22452658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
    Baumann CK; Castiglione-Gertsch M
    Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations in compound database preparation--"hidden" impact on virtual screening results.
    Knox AJ; Meegan MJ; Carta G; Lloyd DG
    J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'tieredScreen' - Layered Virtual Screening Tool for the Identification of Novel Estrogen Receptor Alpha Modulators.
    Yang Y; Carta G; Peters MB; Price T; O'Boyle N; Knox AJ; Fayne D; Williams DC; Meegan MJ; Lloyd DG
    Mol Inform; 2010 May; 29(5):421-30. PubMed ID: 27463197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SeleX-CS: a new consensus scoring algorithm for hit discovery and lead optimization.
    Bar-Haim S; Aharon A; Ben-Moshe T; Marantz Y; Senderowitz H
    J Chem Inf Model; 2009 Mar; 49(3):623-33. PubMed ID: 19231809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving VEGFR-2 docking-based screening by pharmacophore postfiltering and similarity search postprocessing.
    Planesas JM; Claramunt RM; Teixidó J; Borrell JI; Pérez-Nueno VI
    J Chem Inf Model; 2011 Apr; 51(4):777-87. PubMed ID: 21417262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus Computational Ligand-Based Design for the Identification of Novel Modulators of Human Estrogen Receptor Alpha.
    McKay PB; Fayne D; Horn HW; James T; Peters MB; Carta G; Caboni L; Nevin DK; Price T; Bradley G; Williams DC; Rice JE; Lloyd DG
    Mol Inform; 2012 Apr; 31(3-4):246-58. PubMed ID: 27477095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine therapy--current benefits and limitations.
    Nicholson RI; Johnston SR
    Breast Cancer Res Treat; 2005; 93 Suppl 1():S3-10. PubMed ID: 16247594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus scoring criteria for improving enrichment in virtual screening.
    Yang JM; Chen YF; Shen TW; Kristal BS; Hsu DF
    J Chem Inf Model; 2005; 45(4):1134-46. PubMed ID: 16045308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.
    Kurbel S
    Med Hypotheses; 2005; 64(6):1182-7. PubMed ID: 15823713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
    Liu L; Ma H; Tang Y; Chen W; Lu Y; Guo J; Duan JA
    Bioorg Med Chem Lett; 2012 Jan; 22(1):154-63. PubMed ID: 22137340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.